Karriereverlauf von Carolyn Finkle
Ehemalige bekannte Positionen von Carolyn Finkle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | General Counsel | 14.03.2022 | 27.12.2023 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Geschäftsführer | 01.01.2019 | 01.01.2021 |
| General Counsel | 01.01.2019 | 01.01.2021 | |
| PRECIGEN, INC. | General Counsel | - | - |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| IMUNON, INC. | General Counsel | - | - |
Ausbildung von Carolyn Finkle
| University of Ottawa | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 4 |
Operativ
| General Counsel | 4 |
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| IMUNON, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Börse
- Insiders
- Carolyn Finkle
- Erfahrung
